Somerset Therapeutics Private Limited recalls Methocarbamol Injection USP 1
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility: Media fill with bacterial contamination
- Products
-
- Methocarbamol Injection USP 1
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 506,080 vials
- About this recall
- Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)